These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 17255770)
1. Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile. Mottolese M; Orlandi G; Sperduti I; Merola R; Buglioni S; Di Benedetto A; Pinnarò P; Perracchio L; Venturo I; Cognetti F; Cianciulli A Am J Surg Pathol; 2007 Feb; 31(2):247-54. PubMed ID: 17255770 [TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. Rudas M; Lehnert M; Huynh A; Jakesz R; Singer C; Lax S; Schippinger W; Dietze O; Greil R; Stiglbauer W; Kwasny W; Grill R; Stierer M; Gnant MF; Filipits M; Clin Cancer Res; 2008 Mar; 14(6):1767-74. PubMed ID: 18347178 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
4. [Factors predicting failure of adjuvant hormonotherapy of breast carcinoma. A study in tamoxifen treated patients]. Petráková K; Nenutil R; Grell P; Fabian P; Zichová I; Svoboda M; Palácová M; Vyzula R Klin Onkol; 2008; 21(5):303-8. PubMed ID: 19202962 [TBL] [Abstract][Full Text] [Related]
5. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285 [TBL] [Abstract][Full Text] [Related]
6. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection]. Mrhalová M; Kodet R; Strnad P Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908 [TBL] [Abstract][Full Text] [Related]
7. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM; J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968 [TBL] [Abstract][Full Text] [Related]
8. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer. Han S; Park K; Bae BN; Kim KH; Kim HJ; Kim YD; Kim HY J Surg Oncol; 2003 Aug; 83(4):241-7. PubMed ID: 12884237 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer. Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807 [TBL] [Abstract][Full Text] [Related]
10. Adverse genetic prognostic profiles define a poor outcome for cystectomy in bladder cancer. Gallucci M; Vico E; Merola R; Leonardo C; Sperduti I; Felici A; Sentinelli S; Cantiani R; Orlandi G; Cianciulli A Exp Mol Pathol; 2007 Dec; 83(3):385-91. PubMed ID: 17950275 [TBL] [Abstract][Full Text] [Related]
11. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
12. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53. Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265 [TBL] [Abstract][Full Text] [Related]
13. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters. Naidu R; Wahab NA; Yadav MM; Kutty MK Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618 [TBL] [Abstract][Full Text] [Related]
14. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403 [TBL] [Abstract][Full Text] [Related]
15. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization. Diebold J; Mösinger K; Peiro G; Pannekamp U; Kaltz C; Baretton GB; Meier W; Löhrs U J Pathol; 2000 Apr; 190(5):564-71. PubMed ID: 10727982 [TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast. Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078 [TBL] [Abstract][Full Text] [Related]
18. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma? Alvarez T; Miller E; Duska L; Oliva E Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825 [TBL] [Abstract][Full Text] [Related]
19. Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer. Orlando L; Del Curto B; Gandini S; Ghisini R; Pietri E; Torrisi R; Balduzzi A; Cardillo A; Dellapasqua S; Veronesi P; Viale G; Goldhirsch A; Colleoni M Breast; 2008 Oct; 17(5):506-11. PubMed ID: 18456496 [TBL] [Abstract][Full Text] [Related]
20. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification. Jirström K; Stendahl M; Rydén L; Kronblad A; Bendahl PO; Stål O; Landberg G Cancer Res; 2005 Sep; 65(17):8009-16. PubMed ID: 16140974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]